197 related articles for article (PubMed ID: 5805351)
41. Classical maple syrup urine disease: cofactor resistance.
Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
[No Abstract] [Full Text] [Related]
42. [3 patients with maple syrup urine disease].
Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
[TBL] [Abstract][Full Text] [Related]
43. [Simple and rapid determination of leucine by HPLC. Importance for extra-renal treatment of maple syrup urine disease].
Garcia J; Galinier A; Periquet B; Broué P; Decramer S; Thouvenot JP; Caspar-Bauguil S
Ann Biol Clin (Paris); 2002; 60(5):602-6. PubMed ID: 12368147
[No Abstract] [Full Text] [Related]
44. [Maple syrup urine disease].
Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
[No Abstract] [Full Text] [Related]
45. [Long-term dietetic treatment of valine-leucinuria (maple syrup urine disease)].
Schmidt GW
Z Kinderheilkd; 1967; 99(4):273-88. PubMed ID: 5586379
[No Abstract] [Full Text] [Related]
46. [Biochemical-genetic studies in maple syrup disease].
Goedde HW; Blume KG
Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703
[No Abstract] [Full Text] [Related]
47. Maple syrup urine disease--a case report.
Reddy V; Reddy YR; Rao BS; Sivakumar B
Indian Pediatr; 1972 Oct; 9(10):629-33. PubMed ID: 4657784
[No Abstract] [Full Text] [Related]
48. MAPLE-SYRUP-URINE DISEASE. REPORT OF A CASE, WITH A PEDIGREE.
LONSDALE D; BARBER DH
N Engl J Med; 1964 Dec; 271():1338-41. PubMed ID: 14214646
[No Abstract] [Full Text] [Related]
49. [MAPLE SYRUP URINE DISEASE].
TIMMERMANS J
Maandschr Kindergeneeskd; 1963 Oct; 31():337-47. PubMed ID: 14100237
[No Abstract] [Full Text] [Related]
50. Determination of alpha-keto acids as silylated oximes in urine and serum by combined gas chromatography-mass spectrometry.
Sternowsky HJ; Roboz J; Hutterer F; Gaull G
Clin Chim Acta; 1973 Sep; 47(3):371-9. PubMed ID: 4795614
[No Abstract] [Full Text] [Related]
51. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR
Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297
[TBL] [Abstract][Full Text] [Related]
52. Maple syrup urine disease metabolites studies in cerebellum cultures.
Silberberg DH
J Neurochem; 1969 Jul; 16(7):1141-6. PubMed ID: 5816072
[No Abstract] [Full Text] [Related]
53. [Maple syrup urine disease: report of a mild variant case and results of dietary treatment].
Stoppoloni G; Santinelli R; Prisco F; Tolone C; D'Ambrosio M
Pediatria (Napoli); 1978 Sep; 86(3):409-20. PubMed ID: 754161
[No Abstract] [Full Text] [Related]
54. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
[TBL] [Abstract][Full Text] [Related]
55. [The intermittent variant of leucinosis (study of a new case)].
Boisse J; Saudubray JM; Pham-Huu-Trung ; Charpentier C; Castets M; Lemonnier A; Jerome H; Mozziconacci P
Arch Fr Pediatr; 1971 Feb; 28(2):161-77. PubMed ID: 5574022
[No Abstract] [Full Text] [Related]
56. Mild variant of maple syrup urine disease.
Kovács J; Kiss P
Acta Paediatr Acad Sci Hung; 1978; 19(2):137-43. PubMed ID: 707084
[TBL] [Abstract][Full Text] [Related]
57. Experiments of nature involving branch-chain amino acids.
Smith GA
Pediatrics; 1967 Jun; 39(6):811-2. PubMed ID: 6026547
[No Abstract] [Full Text] [Related]
58. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
WESTALL RG
Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992
[No Abstract] [Full Text] [Related]
59. MAPLE SYRUP URINE DISEASE.
SNYDERMAN SE; HOLT LE
J Maine Med Assoc; 1964 Jan; 55():3-5. PubMed ID: 14109847
[No Abstract] [Full Text] [Related]
60. The exclusion of L-isoleucine or of L-leucine from the brain of the rat, caused by raised levels of L-valine in the circulation, and the manner in which this exclusion can be partially overcome.
Daniel PM; Pratt OE; Wilson PA
J Neurol Sci; 1977 Apr; 31(3):421-31. PubMed ID: 845619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
